New study published in @AIDS_Journal: shows switching to injectable cabotegravir/rilpivirine works even without genotypic resistance data. Both groups maintained >93% viral suppression with very low failure rates. Read more ➡ bit.ly/49FEKtN #HIVCare #InjectableART